PneumRx, a BTG International Group company is dedicated to developing innovative technologies in pulmonary medicine. Our flagship Interventional Pulmonology product is a minimally invasive device intended to improve exercise capacity, lung function and quality of life in patients with both heterogeneous and homogeneous emphysema, a kind of COPD. The Coils are made of a shape-memory material called Nitinol, which are then inserted into the diseased parts of the lung during a bronchoscopy procedure. When in place, the Coils are designed to gently regain their shape, gathering up loose, inelastic lung tissue and holding open surrounding airways. The Coils are not a new option for patients with severe emphysema; thousands of patients have been treated in Europe since 2008 and a growing number of countries currently offer the procedure. The Coils are not approved for commercial sale in the United States and are restricted by law to investigational use only in the U.S. Learn more at PneumRx.com